Granted Patent
S1
US 1,117,133 · App. 29/804,808 · Granted Mar 10, 2026
Modular handheld imaging device
Inventors:
Nikola Andric (Toronto, CA); Danielle Dunham (Scarborough, CA); Desmond Hirson (North York, CA); Nitesh Mistry (Toronto, CA); Simon Treadwell (Toronto, CA)
Assignee:
MOLECULIGHT INC.
View Patent ↗
Loading inventors, assignments & file history…
Claims (1)
The ornamental design for a modular handheld imaging device as shown and described.
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded Jan 13, 2025
From: SWK FUNDING LLC
To: MOLECULIGHT INC.
Reel/Frame 069888/0681 →
SECURITY INTEREST
Recorded Jan 2, 2025
From: MOLECULIGHT INC.
To: HAYFIN SERVICES LLP
Reel/Frame 069724/0150 →
SECURITY INTEREST
Recorded Jan 31, 2022
From: MOLECULIGHT INC.
To: SWK FUNDING LLC
Reel/Frame 058917/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 2, 2021
From: ANDRIC, NIKOLA; DUNHAM, DANIELLE; HIRSON, DESMOND; MISTRY, NITESH; TREADWELL, SIMON
To: MOLECULIGHT, INC.
Reel/Frame 057369/0823 →
References Cited (364)
US 3945371A
· Adelman
· 1976
[cited by applicant]
US D389917S
· Hornback
· 1998
[cited by examiner]
US D414867S
· Moriwaki et al.
· 1999
[cited by applicant]
US 5971918A
· Zanger
· 1999
[cited by applicant]
US 6190309B1
· Ooshima et al.
· 2001
[cited by applicant]
US 6393315B1
· Aprahamian et al.
· 2002
[cited by applicant]
US 6571119B2
· Hayashi
· 2003
[cited by applicant]
US 6601997B2
· Ngo
· 2003
[cited by applicant]
US D480478S
· Leonard et al.
· 2003
[cited by applicant]
US 6678398B2
· Wolters et al.
· 2004
[cited by applicant]
US 6889075B2
· Marchitto et al.
· 2005
[cited by applicant]
US D515214S
· Jackson, III et al.
· 2006
[cited by applicant]
US D542820S
· Depay
· 2007
[cited by applicant]
US D548347S
· Ichino
· 2007
[cited by examiner]
US D569378S
· Wanamaker
· 2008
[cited by applicant]
US D573044S
· Kalis
· 2008
[cited by examiner]
US D585554S
· Suzuki
· 2009
[cited by applicant]
US D594356S
· Riddiford
· 2009
[cited by examiner]
US D605759S
· Cuevas et al.
· 2009
[cited by applicant]
US D610178S
· Adolfsson et al.
· 2010
[cited by applicant]
US D613411S
· Collins
· 2010
[cited by examiner]
US 7846091B2
· Fulghum
· 2010
[cited by applicant]
US D636424S
· Lin
· 2011
[cited by applicant]
US D658298S
· Prpa
· 2012
[cited by applicant]
US D677793S
· Prpa
· 2013
[cited by applicant]
US 8620410B2
· Frangioni
· 2013
[cited by applicant]
US D698937S
· Laverack et al.
· 2014
[cited by applicant]
US D701606S
· Ohmukai
· 2014
[cited by applicant]
US D703331S
· Kitayama
· 2014
[cited by applicant]
US D703333S
· Saeki
· 2014
[cited by applicant]
US D724234S
· Hagege
· 2015
[cited by applicant]
US 9042967B2
· Dacosta et al.
· 2015
[cited by applicant]
US D733595S
· Hoshino
· 2015
[cited by applicant]
US D747391S
· Sakai
· 2016
[cited by applicant]
US D748808S
· Matsumura et al.
· 2016
[cited by applicant]
US D750260S
· Sauer
· 2016
[cited by applicant]
US D753308S
· Marinkovich et al.
· 2016
[cited by applicant]
US D755062S
· Yarden
· 2016
[cited by applicant]
US 9326666B2
· Frangioni
· 2016
[cited by applicant]
US 9340490B2
· Okura et al.
· 2016
[cited by applicant]
US 9451882B2
· Nie et al.
· 2016
[cited by applicant]
US D787684S
· Vezina
· 2017
[cited by applicant]
US 9743836B2
· Tsubouchi et al.
· 2017
[cited by applicant]
US D802777S
· Burachynsky et al.
· 2017
[cited by applicant]
US D810293S
· Peel
· 2018
[cited by applicant]
US D820987S
· Tam et al.
· 2018
[cited by applicant]
US D822747S
· Van Deusen et al.
· 2018
[cited by applicant]
US D822748S
· Van Deusen et al.
· 2018
[cited by applicant]
US D825061S
· Parsons
· 2018
[cited by examiner]
US D827014S
· Sakai
· 2018
[cited by applicant]
US D835271S
· Myers et al.
· 2018
[cited by applicant]
US D849105S
· Hogstedt et al.
· 2019
[cited by applicant]
US D850628S
· De Hoog et al.
· 2019
[cited by applicant]
US D859498S
· Lin
· 2019
[cited by applicant]
US D861176S
· Yoon et al.
· 2019
[cited by applicant]
US D861764S
· Zhao
· 2019
[cited by applicant]
US D862697S
· Kenworthy et al.
· 2019
[cited by applicant]
US D865836S
· Puusaari
· 2019
[cited by applicant]
US D865845S
· Sakai
· 2019
[cited by applicant]
US D866764S
· Pukall
· 2019
[cited by applicant]
US D868867S
· Jean et al.
· 2019
[cited by applicant]
US D873890S
· Fidler
· 2020
[cited by applicant]
US D884175S
· Aubailly et al.
· 2020
[cited by applicant]
US D897535S
· Rainville
· 2020
[cited by examiner]
US D907097S
· Suurmeijer
· 2021
[cited by examiner]
US D908161S
· Dacosta
· 2021
[cited by examiner]
US D908881S
· Dacosta et al.
· 2021
[cited by applicant]
US D910105S
· Lin
· 2021
[cited by applicant]
US D910182S
· Dacosta et al.
· 2021
[cited by applicant]
US D913354S
· Marzette, Jr. et al.
· 2021
[cited by applicant]
US D914220S
· Nelson et al.
· 2021
[cited by applicant]
US D916294S
· Murray et al.
· 2021
[cited by applicant]
US D919093S
· Takahashi
· 2021
[cited by applicant]
US D919690S
· Suurmeijer et al.
· 2021
[cited by applicant]
US D921736S
· Yin
· 2021
[cited by applicant]
US D921899S
· Suarez et al.
· 2021
[cited by applicant]
US D922469S
· Sjogren et al.
· 2021
[cited by applicant]
US D924306S
· Melnicoff
· 2021
[cited by applicant]
US D930845S
· Schmidt et al.
· 2021
[cited by applicant]
US D936827S
· Wang
· 2021
[cited by applicant]
US D951456S
· Ooshima
· 2022
[cited by examiner]
US D952023S
· Dacosta
· 2022
[cited by examiner]
US D958991S
· Dacosta et al.
· 2022
[cited by applicant]
US D959666S
· Dacosta et al.
· 2022
[cited by applicant]
US D967420S
· Sun
· 2022
[cited by applicant]
US D967433S
· Ai-Ali
· 2022
[cited by examiner]
US 20010049473A1
· Hayashi
· 2001
[cited by applicant]
US 20020150352A1
· Ngo
· 2002
[cited by applicant]
US 20030191368A1
· Wang et al.
· 2003
[cited by applicant]
US 20040225222A1
· Zeng et al.
· 2004
[cited by applicant]
US 20050029437A1
· Hasegawa et al.
· 2005
[cited by applicant]
US 20050234526A1
· Gilhuly et al.
· 2005
[cited by applicant]
US 20050288594A1
· Lewkowicz et al.
· 2005
[cited by applicant]
US 20060004292A1
· Beylin
· 2006
[cited by applicant]
US 20060241493A1
· Feldman et al.
· 2006
[cited by applicant]
US 20080059070A1
· Boyden et al.
· 2008
[cited by applicant]
US 20080108869A1
· Sanders et al.
· 2008
[cited by applicant]
US 20080188758A1
· Campbell et al.
· 2008
[cited by applicant]
US 20090137908A1
· Patwardhan
· 2009
[cited by applicant]
US 20100084563A1
· Ohno
· 2010
[cited by applicant]
US 20100145146A1
· Melder
· 2010
[cited by applicant]
US 20100145419A1
· Fraval
· 2010
[cited by applicant]
US 20100292580A1
· Gilhuly et al.
· 2010
[cited by applicant]
US 20110117025A1
· Dacosta et al.
· 2011
[cited by applicant]
US 20110275900A1
· Gilhuly et al.
· 2011
[cited by applicant]
US 20110305422A1
· Thompson et al.
· 2011
[cited by applicant]
US 20120016230A1
· Kishima et al.
· 2012
[cited by applicant]
US 20120101390A1
· Iftimia et al.
· 2012
[cited by applicant]
US 20120165627A1
· Yamamoto
· 2012
[cited by applicant]
US 20120323124A1
· Corbett, III et al.
· 2012
[cited by applicant]
US 20130338479A1
· Pogue et al.
· 2013
[cited by applicant]
US 20140180116A1
· Lindekugel et al.
· 2014
[cited by applicant]
US 20140275772A1
· Chuda
· 2014
[cited by applicant]
US 20150030542A1
· Singhal
· 2015
[cited by applicant]
US 20150038837A1
· Inoue et al.
· 2015
[cited by applicant]
US 20150150460A1
· Krishnaswamy et al.
· 2015
[cited by applicant]
US 20150182196A1
· Ninomiya et al.
· 2015
[cited by applicant]
US 20150198797A1
· Andre et al.
· 2015
[cited by applicant]
US 20150230696A1
· Tuch et al.
· 2015
[cited by applicant]
US 20160062103A1
· Yang et al.
· 2016
[cited by applicant]
US 20160206202A1
· Frangioni
· 2016
[cited by applicant]
US 20160287194A1
· Nariyuki et al.
· 2016
[cited by applicant]
US 20160287211A1
· DaCosta et al.
· 2016
[cited by applicant]
US 20170000320A1
· Wilson et al.
· 2017
[cited by applicant]
US 20170143418A1
· Lee
· 2017
[cited by applicant]
US 20170156597A1
· Whitehead
· 2017
[cited by applicant]
US 20170236281A1
· Dacosta
· 2017
[cited by applicant]
US 20170280969A1
· Levy et al.
· 2017
[cited by applicant]
US 20170290515A1
· Butte et al.
· 2017
[cited by applicant]
US 20180098741A1
· Lu et al.
· 2018
[cited by applicant]
US 20180133320A1
· Babic et al.
· 2018
[cited by applicant]
US 20180218508A1
· Lee et al.
· 2018
[cited by applicant]
US 20180279864A1
· Frangioni
· 2018
[cited by applicant]
US 20180369603A1
· Gjersvik et al.
· 2018
[cited by applicant]
US 20210228300A1
· DaCosta et al.
· 2021
[cited by applicant]
US 20220248944A1
· Dacosta et al.
· 2022
[cited by applicant]
US 20240265544A1
· Hirson
· 2024
[cited by examiner]
AU 2014373656
· 2016
[cited by applicant]
CA 208795
· 2022
[cited by applicant]
CN 101208037
· 2008
[cited by applicant]
CN 103654699
· 2014
[cited by applicant]
CN 104271046
· 2015
[cited by applicant]
CN 104394754
· 2015
[cited by applicant]
CN 105212880
· 2016
[cited by applicant]
CN 106714670
· 2017
[cited by applicant]
CN 106983495
· 2017
[cited by applicant]
CN 107093171
· 2017
[cited by applicant]
CN 304554755
· 2018
[cited by applicant]
CN 108289723
· 2018
[cited by applicant]
CN B06141139
· 2020
[cited by applicant]
CN 307182522
· 2022
[cited by applicant]
CN 307545922
· 2022
[cited by applicant]
CN 307713119
· 2022
[cited by applicant]
EM 0066247630002
· 2019
[cited by applicant]
EP 1880660
· 2008
[cited by applicant]
EP 2502551
· 2012
[cited by applicant]
EP 3372143
· 2018
[cited by applicant]
EP 4284131
· 2023
[cited by applicant]
JP H08224208
· 1996
[cited by applicant]
JP H09000488
· 1997
[cited by applicant]
JP H10151104
· 1998
[cited by applicant]
JP 2003190091
· 2003
[cited by applicant]
JP 2004305367
· 2004
[cited by applicant]
JP 2005124776
· 2005
[cited by applicant]
JP 2006509573
· 2006
[cited by applicant]
JP 2006166940
· 2006
[cited by applicant]
JP 2006340796
· 2006
[cited by applicant]
JP 2007244746
· 2007
[cited by applicant]
JP 2009045148
· 2009
[cited by applicant]
JP 2009066121
· 2009
[cited by applicant]
JP 2011521237
· 2011
[cited by applicant]
JP 2012532689
· 2012
[cited by applicant]
JP 2013514156
· 2013
[cited by applicant]
JP 2013123647
· 2013
[cited by applicant]
JP 2013531538
· 2013
[cited by applicant]
JP 2015139613
· 2015
[cited by applicant]
JP 2016030214
· 2016
[cited by applicant]
JP 2016520339
· 2016
[cited by applicant]
JP 2017060778
· 2017
[cited by applicant]
JP 2017524935
· 2017
[cited by applicant]
JP 2017192501
· 2017
[cited by applicant]
JP 2024160225
· 2024
[cited by applicant]
JP 7648525
· 2025
[cited by applicant]
KR 101503891
· 2015
[cited by applicant]
KR 3008275160000
· 2015
[cited by applicant]
KR 1020160065258
· 2016
[cited by applicant]
WO 2010080611
· 2010
[cited by applicant]
WO 2013184830
· 2013
[cited by applicant]
WO 2016011534
· 2016
[cited by applicant]
WO 2016063949
· 2016
[cited by applicant]
WO 2017079844
· 2017
[cited by applicant]
WO 2017082242
· 2017
[cited by applicant]
WO 2017096137
· 2017
[cited by applicant]
WO 2018145193
· 2018
[cited by applicant]
WO 2019148268
· 2019
[cited by applicant]
WO 20190213737
· 2019
[cited by applicant]
WO 2020148724
· 2020
[cited by applicant]
WO 2020148725
· 2020
[cited by applicant]
WO 2020148726
· 2020
[cited by applicant]
Launch of New MolecuLightDX™ Device, Oct. 14, 2021, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://moleculight.com/news/launch-of-new-moleculightdx-device-to-enable-point-of-care-imaging-of-wounds-in-…
[cited by examiner]
Launch of New MolecuLightDX™ Device, Oct. 14, 2021, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://www.prnewswire.com/news-releases/launch-of-new-moleculightdx-device-to-enable-point-of-care-imaging-o…
[cited by examiner]
MolecuLight launches DX device, Oct. 15, 2021, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://vascularnews.com/moleculight-launces-dx-device/> (Year: 2021).
[cited by examiner]
MolecuLight secures group purchasing deal, Sep. 30, 2022, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://www.medicaldevice-network.com/news/moleculight-wound-imaging/> (Year: 2022).
[cited by examiner]
Office Action dated May 23, 2024 in MX Application No. MX/f/2022/000423.
[cited by applicant]
Notice of Grant dated Jun. 11, 2024 in JP Application No. 2021-541486.
[cited by applicant]
Notice of Allowance dated May 27, 2024 in MX/f/2024/000967.
[cited by applicant]
Notice of Allowance dated May 27, 2024 in MX/f/2024/000968.
[cited by applicant]
Office Action dated Jul. 16, 2024 received in JP Application No. 2021-541493.
[cited by applicant]
Office Action dated Jul. 16, 2024 received in JP Application No. 2021-541474.
[cited by applicant]
Notice of Allowance dated Jun. 11, 2024 in CA Application No. 3, 127,048.
[cited by applicant]
Office Action dated Jun. 28, 2024 received in CN Application No. 2019800233835.
[cited by applicant]
Office Action dated Jul. 4, 2024 received in CN Application No. 2020800191924.
[cited by applicant]
U.S. Appl. No. 62/793,842, dated Jan. 17, 2019.
[cited by applicant]
U.S. Appl. No. 62/793,846, dated Jan. 17, 2019.
[cited by applicant]
U.S. Appl. No. 62/857,183, dated Jun. 4, 2019.
[cited by applicant]
Design U.S. Appl. No. 29/676,901, dated Jan. 15, 2019.
[cited by applicant]
Design U.S. Appl. No. 29/677,152, dated Jan. 17, 2019.
[cited by applicant]
International Search Report and Written Opinion from International Patent Application No. PCT/CA2019/000015, dated Jun. 4, 2019.
[cited by applicant]
“Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy”, 2017, Gao et al. https://www.researchgate.net/publication/315469453 Fluorescent chemical probes for accurate tumor diagnosis and targetin…
[cited by applicant]
“Current concepts and future perspectives on surgical optical imaging in cancer”,2010, Ntziachristos et al , https://www.sniedigitallibrary.orMoumals/Jounial-of-Biomedical-Onticstvolume-15issue-61066024/Current-concepts…
[cited by applicant]
Notice of Allowance in Design U.S. Appl. No. 29/677,154, dated Apr. 1, 2020.
[cited by applicant]
Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Apr. 1, 2020.
[cited by applicant]
Ex Parte Quayle Action in Design U.S. Appl. No. 29/676,901, dated Mar. 5, 2020.
[cited by applicant]
Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Jun. 4, 2020.
[cited by applicant]
International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050384 dated Apr. 22, 2020.
[cited by applicant]
International Patent Application No. PCT/IB2020/050384, dated Jan. 17, 2020.
[cited by applicant]
International Patent Application No. PCT/IB2020/050383, dated Jan. 17, 2020.
[cited by applicant]
International Patent Application No. PCT/IB2020/050385, dated Jan. 17, 2020.
[cited by applicant]
International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050385 dated Apr. 8, 2020.
[cited by applicant]
Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Sep. 22, 2020.
[cited by applicant]
Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Sep. 18, 2020.
[cited by applicant]
Ex Parte Quayle Action in Design U.S. Appl. No. 29/677,152, dated Dec. 20, 2019.
[cited by applicant]
Design U.S. Appl. No. 29/762,417, dated Dec. 16, 2020.
[cited by applicant]
Design U.S. Appl. No. 29/767,502, dated Jan. 22, 2021.
[cited by applicant]
U.S. Appl. No. 17/423,447, dated Jul. 15, 2021.
[cited by applicant]
U.S. Appl. No. 17/423,576, dated Jul. 16, 2021.
[cited by applicant]
U.S. Appl. No. 17/423,609, dated Jul. 16, 2021.
[cited by applicant]
Office Action dated Aug. 17, 2021 in related U.S. Appl. No. 29/762,417, 9 pages.
[cited by applicant]
European Search Report for EP Application No. EP19746801 dated Sep. 13, 2021, 2 pages.
[cited by applicant]
“Nagaya et al Fluorescence-Guided Surgery”, Frontiers in Oncology, vol. 7, Dec. 22, 2017, 16 pp.
[cited by applicant]
Notice of Allowance in Design U.S. Appl. No. 29/762,417, dated Jan. 13, 2022, 13 pages.
[cited by applicant]
Notice of Allowance in Design U.S. Appl. No. 29/767,502 dated Mar. 11, 2022, 5 pages.
[cited by applicant]
Notice of Allowance in U.S. Appl. No. 29/767,874 dated Mar. 21, 2022.
[cited by applicant]
Examination Report dated Mar. 24, 2022 in IN App No. 358348-001.
[cited by applicant]
Examination Report dated Mar. 24, 2022 in IN App No. 358347-001.
[cited by applicant]
Supplementary Partial European Search report dated Sep. 20, 2022 in related EP Application No. 20740856.8, 12 pages.
[cited by applicant]
Supplementary European Search report dated Sep. 20, 2022 in related EP Application No. 20741034.1, 27 pages.
[cited by applicant]
Supplementary European Search report dated Sep. 26, 2022 in related EP Application No. 20741678.5, 9 pages.
[cited by applicant]
Office Action dated Sep. 16, 2022 in related CA Application No. 3,127,036.
[cited by applicant]
Notice of Allowance dated Sep. 27, 2022 in related JP Application No. 2022-003401.
[cited by applicant]
Office Action dated Oct. 6, 2022 in related CA Application No. 3,127,048.
[cited by applicant]
7 Office Action dated Sep. 27, 2022 in related JP Application No. 2022-019073.
[cited by applicant]
European Search report dated Jan. 5, 2023 in related EP Application No. 20740856.8.
[cited by applicant]
First Examination report dated Feb. 3, 2023 in related IN App No. 202117030136.
[cited by applicant]
Office Action dated Sep. 2, 2024 received in EP Application No. 19746801.0.
[cited by applicant]
Office Action dated Sep. 3, 2024 received in JP Application No. 2023-199730.
[cited by applicant]
Office Action dated Jul. 25, 2024 in MX Application No. MX/a/2021/008504.
[cited by applicant]
Examination Report dated Sep. 6, 2024 received in AU Application No. 2020209518.
[cited by applicant]
Examination Report dated Sep. 5, 2024 received in AU Application No. 2020209276.
[cited by applicant]
Office Action dated Aug. 6, 2024 received in CN Application No. 2020800219686.
[cited by applicant]
Notice of Allowance dated Jan. 20, 2025 received in MX Application No. MX/a/2021/008504.
[cited by applicant]
Notice of Grant dated Feb. 4, 2025 in JP Application No. 2021-541474.
[cited by applicant]
Office Action dated Feb. 4, 2025 received in JP Application No. 2021-541493.
[cited by applicant]
Office Action dated Feb. 12, 2025 in JP Application No. 2020-541946.
[cited by applicant]
Office Action dated Jan. 1, 2025 received in JP Application No. 2020800219686.
[cited by applicant]
Notice of Allowance dated Feb. 24, 2025 received in MX Application No. MX/a/2020/008159.
[cited by applicant]
Office Action dated Feb. 12, 2025 in CN Application No. 2020800191924.
[cited by applicant]
Office Action dated Mar. 11, 2025 in JP Application No. 2023-199730.
[cited by applicant]
Masafumi Oyama et al., “Application of PDD to renal cell carcinoma”, Japanese Journal of Endourology, vol. 24, Japanese Society of Endourology and Robotics, 2011, p. 23-28, URL:https://www.j stage.j st.go.jp/ article/j …
[cited by applicant]
Office Action dated Mar. 14, 2025 in CA Application No. 3,090,190.
[cited by applicant]
SnapshotNIR, www.woundsource.com, Jan. 25, 2017, URL:https://www.bing.com/images/search?view=detailV2&ccid=2SJ6i4ko&id=C2EDCF8F23663F9D7A426C6045D60816D88E820D&thid.
[cited by applicant]
U.S. Appl. No. 29/842,182 filed Jun. 10, 2022.
[cited by applicant]
U.S. Appl. No. 29/842,512, filed Jun. 14, 2022.
[cited by applicant]
Office Action dated Jun. 21, 2022 in family member Brazilian Application No. BR 302022000890-7.
[cited by applicant]
Office Action dated Jul. 13, 2023 in CA Application No. 3,127,048.
[cited by applicant]
Decision Of Rejection dated Jul. 25, 2023 in JP Application No. 2020-541946.
[cited by applicant]
Office Action dated Jul. 14, 2023 in CA Application No. 3, 127,036.
[cited by applicant]
Notification of the First Rectification dated Jul. 5, 2023 in CN Application No. 2022300861326.
[cited by applicant]
Office Action dated Jun. 20, 2023 received in JP Application No. 2023-003578.
[cited by applicant]
Examination Report dated Aug. 10, 2023 in CA Application No. 210515.
[cited by applicant]
Office Action dated Oct. 3, 2023 received in Design U.S. Appl. No. 29/842,512, 8 pages.
[cited by applicant]
BayCare, Lumicell, Inc. Selects BayCare for Pivotal Breast Cancer Trial, Published on: Oct. 9, 2020, Baycare.org, Retrieved from Internet: https://baycare.org/newsroom/2020/october/lumicell-inc-selects-baycare-for-pivot…
[cited by applicant]
Office Action dated Oct. 3, 2023 received in JP Application No. 2021-541493.
[cited by applicant]
Office Action dated Oct. 3, 2023 received in JP Application No. 2021-541474.
[cited by applicant]
Notice of Allowance dated Oct. 13, 2023 in Design U.S. Appl. No. 29/842,182, 9 pages.
[cited by applicant]
Advanced Endoscopy Devices, Inc, Introducing the Multi-Disciplinary Use of the Aed Endopro-Cam® Elite, Uploaded on: Mar. 11, 2020, YouTube, Retrieved from Internet: https://www.youtube.com/watch?v=rnxtMz2JhFg (Year: 202…
[cited by applicant]
SBI ALAPharma, The Eagle V1.2 Imaging System, Downloaded on: Aug. 22, 2023, sbi-alapharmacanada.ca, Retrieved from Internet: https://www.sbi-alapharmacanada.ca/technology (Year: 2023).
[cited by applicant]
Action dated Nov. 7, 2023 received in JP Patent Application No. 2021-541486.
[cited by applicant]
Action dated Sep. 27, 2023 received in CN Patent Application No. 2020800191924.
[cited by applicant]
Action dated Nov. 4, 2023 received in CA Patent Application No. 225,390.
[cited by applicant]
Office Action dated Sep. 28, 2023 received in CN Patent Application No. 2019800233835.
[cited by applicant]
Examination report dated Nov. 30, 2023 received in AU Patent Application No. 2019215811.
[cited by applicant]
European Search Report dated Jan. 12, 2024 received in EP Patent Application No. 23188747.2.
[cited by applicant]
Office Action dated Jan. 17, 2024 in CN Patent Application No. 2020800184047.
[cited by applicant]
Office Action dated Jan. 24, 2024 in U.S. Appl. No. 16/966,293, 18 pp.
[cited by applicant]
Office Action dated Oct. 12, 2023 in CN Patent Application No. 2020800219686.
[cited by applicant]
Office Action dated Jan. 11, 2024 in CN Patent Application No. 2022300861326.
[cited by applicant]
Notice of Allowance dated Feb. 5, 2024 in Design U.S. Appl. No. 29/842,512.
[cited by applicant]
Office Action dated Feb. 20, 2024 in U.S. Appl. No. 17/423,447, 25 pp.
[cited by applicant]
Office Action dated Feb. 22, 2024 in U.S. Appl. No. 17/423,576, 26 pp.
[cited by applicant]
Office Action dated Jan. 26, 2024 in MX Patent Application No. MX/f/2022/000423.
[cited by applicant]
Office Action dated Mar. 27, 2024 in CA Application No. 3,127,039.
[cited by applicant]
Office Action dated Mar. 28, 2024 in CA Application No. 3,090,190.
[cited by applicant]
Office Action dated Apr. 3, 2024 in CN Application No. 2019800233835.
[cited by applicant]
Office Action dated Nov. 20, 2024 received in MX Application No. MX/a/2020/008159.
[cited by applicant]
Notice of Issuance dated Nov. 22, 2024 in CN Application No. 2024301422414.
[cited by applicant]
Office Action dated Oct. 24, 2024 in Canadian Application No. 3,127,036.
[cited by applicant]
Corrected Notice of Allowability dated Jan. 8, 2025 received in U.S. Appl. No. 17/423,447.
[cited by applicant]
Office Action dated Apr. 4, 2023 received in related JP Application No. 2020-541946.
[cited by applicant]
Written Opinion dated Apr. 21, 2023 in related Application No. 11202107275Q.
[cited by applicant]
Office Action dated Sep. 26, 2024 in U.S. Appl. No. 17/423,609, 52 pp.
[cited by applicant]
Examination Report dated Sep. 27, 2024 received in AU Application No. 2020208843.
[cited by applicant]
Notice of Allowance dated Oct. 30, 2024 received in U.S. Appl. No. 17/423,447, 7 pp.
[cited by applicant]
Office Action dated Oct. 16, 2024 received in CN Application No. 2019800233835.
[cited by applicant]
Final Office Action dated Nov. 1, 2024 received in U.S. Appl. No. 17/423,576, 22 pages.
[cited by applicant]
Final Office Action dated Nov. 7, 2024 received in U.S. Appl. No. 16/966,293, 21 pp.
[cited by applicant]
Office Action dated Nov. 14, 2024 received in Korean Application No. 10-2021-7026033.
[cited by applicant]
Corrected Notice of Allowability dated Nov. 27, 2024 received in U.S. Appl. No. 17/423,447.
[cited by applicant]
Office Action dated Oct. 17, 2024 received in CN Application No. 2020800184047.
[cited by applicant]
Office Action dated Apr. 22, 2024 received in MX Application No. MX/a/2020/008159.
[cited by applicant]
First Examination report dated Jun. 30, 2022 in related IN App No. 202017037681.
[cited by applicant]
Application and Drawings filed Mar. 10, 2025 in U.S. Appl. No. 19/075,323.
[cited by applicant]
Notice of Issuance dated May 19, 2025 in CN Application No. 2020800184047.
[cited by applicant]
Office Action dated Jun. 5, 2025 in EP Application No. 20741034.1.
[cited by applicant]
Office Action dated Jun. 13, 2025 received in U.S. Appl. No. 17/423,576, 18 pages.
[cited by applicant]
Notice of Allowance dated Jul. 1, 2025 for U.S. Appl. No. 17/423,609.
[cited by applicant]
Office Action dated Jul. 18, 2025 in CA Application No. 3,127,039.
[cited by applicant]
Office Action dated Jul. 23, 2025 received in KR Application No. 10-2021-7026039.
[cited by applicant]
Office Action dated Jul. 29, 2025 received in JP Application No. 2024-110804.
[cited by applicant]
Office Action dated Aug. 13, 2025 received in U.S. Appl. No. 16/966,293, 25 pages.
[cited by applicant]